Posts in category

Clinical


Concerns grow over discontinuation of “gold standard” pain relief brand Ordine from later this year A group of 18 palliative care organisations led by Palliative Care Australia is calling for …

SHPA welcomes support for post-discharge medicine supply and the successful trial of a new liquid opioid management system A major New South Wales government announcement meets long-standing requests for post-discharge …

Methadone, buprenorphine, drug testing, naloxone and more: we discuss the latest views and opinions with a panel of experts Why is the naloxone program not seeing wider take-up? Should pharmacists …

Pharmacists are running out of time and energy to fix problems with the new national methadone Pharmaceutical Benefits Scheme (PBS) system  Clerical drama surrounding changes to opioid management programs, combined …

Call for more widespread adoption of medication charting in cancer units following study findings Use of Partnered Pharmacist Medication Charting (PPMC) in oncology units is associated with significantly lower rates …

PBAC recommends extending eligibility criteria for Covid medication to an additional population group    In an out-of-session consideration, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended changes to the circumstances …

Daily aspirin use increases risk by 20% according to new study Older adults who take low-dose aspirin over a prolonged period should be regularly monitored for anaemia, researchers into aspirin use …

Pharmacists conducting medicines reviews often come across complementary medicines and “weird stuff” that aren’t right for patients…but how can they best advise on them? If double dispensing helps fuel medicine …

Managing urinary tract infections (UTIs) is less of a leap in terms of the expansion of pharmacists’ scope of practice than vaccination was  Pharmacy graduates are “well equipped” to assist …

New TGA data shows four of the 325 medicines slated for 60-day dispensing are in short supply  Pharmacists’ claims that double dispensing will exacerbate medicines shortages are not accurate, Professor …

We look at some of the recent changes to the medicines landscape, with new products, new indications and safety related changes  New Products Deucravacitinib (Sotyktu) is a small molecule that …

Stakeholders have until 24 July to share their views on the Pharmacy Board of Australia’s draft revised Guidelines on compounding of medicines  The Pharmacy Board of Australia has opened a …